A Study of LY3337641 in Healthy Participants

Summary

The purposes of this study are to determine: * If there are any differences in the amount of LY3337641 in the blood/body when it is taken in different formulations. A total of 3 different formulations of LY3337641 are being tested. * How a high-fat meal affects the amount of LY3337641 in the blood/body. * How safe and well tolerated LY3337641 is. The study has four periods. Individuals will participate in all four periods. Each period will include 4 overnight stays (5 days) in the Clinical Research Unit (CRU). This study is expected to last up to 8 weeks. This includes the initial screening period, the study or dosing period, and the follow up period.

Timeline

Start

2017-04-04

Primary completion

2017-05-31

Completion

2017-05-31

Drugs

Indications

No indication recorded.